ClinicalTrials.gg
Not yet recruitingNCT07016828Updated Jun 12, 2025

Guided Pterygoid Implant

An interventional study of guided surgery technique and Free hand technique in Atrophy of the Posterior Maxilla, sponsored by Fayoum University. Not yet recruiting at 1 site in Egypt. Open to participants aged 21 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-06-12.

Sponsored by Fayoum University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
21 Years to 75 Years
Sex
All
01

Study summary

Introduction \& Background Alveolar ridge resorption after tooth extraction leads to significant bone loss, complicating prosthetic rehabilitation. Traditional bone grafting methods, though effective, involve long healing times and risks. Pterygoid implants offer a graft-free alternative by engaging dense bone structures like the pterygoid process. However, their placement is technically challenging due to limited visibility and proximity to critical structures. Computer-guided surgery may improve accuracy and reduce complications compared to freehand techniques.

Research Question Does computer-guided surgery enhance the accuracy of pterygoid implant placement in atrophic maxillae compared to freehand techniques? Aim To compare the accuracy of computer-generated 3D surgical guides versus freehand placement of pterygoid implants.

Hypothesis

  • H0: No difference in accuracy between techniques.
  • Hₐ: there is difference between two techniques Study Design A prospective randomized controlled trial (1:1 allocation) with 12 implants (6 per group(.

Patient Selection Inclusion Criteria: Severe posterior maxillary atrophy (Cawood \& Howell V-VI), residual bone height \<4mm, age 21-75.

Exclusion Criteria: Contraindications for surgery, uncontrolled systemic diseases, or acute sinus infections.

Methods

  • Group A: Implants placed using CBCT-based 3D surgical guides.
  • Group B: Freehand placement based on anatomical landmarks.
  • Primary Outcome: Implant position accuracy (postoperative CBCT vs. virtual plan(.
  • Secondary Outcomes: Surgical time, complications, and stability. Surgical Procedure
  • Osteotomy: Angled drilling (45-60°) into the pterygoid process.
  • Implant Placement: Torque ≥30 Ncm for primary stability.
  • Postoperative Care: Antibiotics, analgesics, and follow-up CBCT at one week. Statistical Analysis Data analyzed using SPSS, with G*Power determining sample size (85% power, α = 0.05(.

Ethical Considerations Approved by institutional review boards, with informed consent and confidentiality maintained.

02

Conditions studied

  • Atrophy of the Posterior Maxilla

Browse trials for

Keywords

  • guided surgery
  • pterygoid implant
  • atrophic maxilla
03

In context

Atrophic Maxilla

30 studies on the registry are indexed under Atrophic Maxilla; 11 are open to participants now.

This study's planned enrollment of 12 is below the median of 16 across 27 interventional studies indexed under Atrophic Maxilla.

Browse Atrophic Maxilla studies →

Lead sponsor

Fayoum University is the lead sponsor of 148 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients with severe posterior maxillary atrophy (Class V-VI Cawood \& Howell classification) requiring pterygoid implant placement.
  2. Patients with severe alveolar bone atrophy in posterior maxilla (Residual alveolar bone height \<4mm in posterior maxilla precluding conventional implant placement).
  3. Adequate interarch space ≥7mm for prosthetic rehabilitation.
  4. Presence of pneumatized maxillary sinus with insufficient bone for sinus augmentation.
  5. Patients aged 21-75 years with completed craniofacial growth.

Exclusion criteria

Exclusion Criteria:

  1. Patients with systemic conditions contra-indicating general anesthesia.
  2. Patients with conditions contraindicating implant placement (e.g.:

    radiation to the head and neck, intra-venous bisphosphonates, uncontrolled Diabetes mellitus).

  3. Patients with acute maxillary sinus infection or maxillary sinus cyst.
  4. Restricted mouth opening (less than 3cm inter-arch distance anteriorly).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
12 participants (estimated)

Study arms

  • Active comparator
    Guided Surgery group

    Implants placed using CBCT-based 3D surgical guides.

    Device: guided surgery technique

  • Placebo comparator
    free hand technique group

    Freehand placement based on anatomical landmarks.

    Procedure: Free hand technique

Interventions

  • Deviceguided surgery technique

    * Clinical examination will be performed and preoperative CBCT will be taken for all the patients prior to the surgery to evaluate the posterior maxilla for the placement of the pterygoid implants. * Ideal pterygoid implant placement will be planned using the BlueSky Bio software (USA) which will be mostly to emerge from the third molar position and to engage the dense pillar of bone formed by the pyramidal process and pterygoid process of sphenoid bone. * surgical guide will be fabricated which will be either soft tissue without flap elevation.

  • ProcedureFree hand technique

    the surgery will be done without the use of the surgical guides depending on the anatomical landmarks.

06

What researchers measure

Primary outcomes

  1. Accuracy of implant position

    The primary outcome will be measured by comparing the position of implant in the virtual plan with that in the postoperative implant or the actual implant and this will be done by making a superimposition of the virtual plan with the postoperative CBCT then putting points on the coronal and apical parts of implants and then start to measure the following data: 1. direct linear measurements between the coronal and apical points of the virtual and actual implants (measured in millimeters) 2. angular deviations between the long axis of virtual and postoperative or actual implants.(measured in degrees) 3. indirect measurements of the coronal and apical points of virtual and actual implants to 3d planes.(measured in mm) All of this will be done for both groups.

    Time frame: the patient will make postoperative CBCT after one week of the surgery to compare it with the preoperative virtual planning done on the preoperative CBCT.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided — I still have no decision until i start my research and getting approvals from the patients to protect their right.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2025; primary completion for Jun 2026, 10 months later.

Of 20 interventional studies with no phase under Atrophic Maxilla, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 32. This study's planned 10 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2025
First posted
Jun 12, 2025
StartEst.
Jul 30, 2025
Primary completionEst.
Jun 1, 2026
CompletionEst.
Jun 30, 2026
Last update
Jun 12, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07016828
Lead sponsor
Fayoum University
Responsible party
Norhan Magdy Ahmed Yousef (dentist in medical administration at fayoum university, Fayoum University) — Principal investigator
First posted
Jun 12, 2025
Start date
Jul 30, 2025 (estimated)
Primary completion
Jun 1, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Jun 12, 2025

Study contacts

norhan magdy yousef, BDs
Contact
nm2650@fayoum.edu.eg
+201067534200
al shimaa ahmed shaban, professor
Contact
aas16@fayoum.edu.eg
+201006047940

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion